Joseph, S., Kaleebu, P., Ruzagira, E., Hansen, C. H., Seeley, J., Basajja, V., Weber, J., Fox, J., Kingsley, C., Aboud, S., Lyamuya, E., Maganga, L., Pamba, D., Ramjee, G., Yssel, J., Viegas, E., Jani, I., Priddy, F., Nilsson, C., Kroidl, A., Pantaleo, G., Robb, M., Crook, A., Dunne, D., & Mccormack, S. (n.d.). oC 8491 PREPVacc: a phase III, MAMS adaptive prophylactic HIV vaccine trial with a second randomisation to compare F/TAF with TDF/FTC prep. BMJ global health, 4, A10. http://access.bl.uk/ark:/81055/vdc_100137785113.0x000002